Serum glycomic profile as a predictive biomarker of recurrence in patients with differentiated thyroid cancer.

Matthew R KudelkaYi LasanajakDavid F SmithXuezheng SongMohammad S HossainTaofeek Kunle Owonikoko

Published in: Cancer medicine (2022)

Altered N-glycomic profile was associated with thyroid cancer recurrence. This serum-based biomarker would be useful as an effective surveillance tool to improve the care and prognosis of thyroid cancer after prospective validation.

Keyphrases

healthcare
free survival
palliative care
public health
quality improvement
chronic pain